Skip to main content
Log in

Cost effective approaches to prevent allopurinol hypersensitivity

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. estimated glomerular filtration rate

Reference

  • Zhu Y, et al. Utility of HLA-B5801 Genotyping and Renal Dosing of the Starting Dose of Allopurinol in Preventing Allopurinol Hypersensitivity Syndrome: A Cost-Effectiveness Analysis.76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals : abstr. 742, 9 Nov 2012. Available from: URL: http://www.rheumatology.org/apps/MyAnnualMeeting/ExploreMeeting/AbstractDetail?abstractId=27891

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cost effective approaches to prevent allopurinol hypersensitivity. PharmacoEconomics & Outcomes News 669, 5 (2013). https://doi.org/10.1007/s40274-013-0051-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0051-0

Navigation